Skip to content

Web-Based and Tailored Asthma Management Intervention (Puff City) in Teens With Asthma Attending Urban Clinics

Pragmatic Randomized Controlled Trial of the Web-Based Asthma Management Intervention (Puff City) in Teens With Asthma Attending Urban Clinics

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT01757002
Acronym
PCC
Enrollment
266
Registered
2012-12-28
Start date
2013-03-31
Completion date
2016-11-30
Last updated
2017-08-09

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Asthma

Keywords

Urban adolescents, Acute asthma, Asthma, Computer tailoring, Web-based intervention, Puff City

Brief summary

The purpose of this study is to evaluate the Puff City web-based behavioral intervention of asthma management program in a clinical setting. This study also examines and evaluates the cost and efficiency of patient eligibility determination methods, patient recruitment, study monitoring (compliance with study regimen, participant retention and follow-up), and the collection of clinical endpoints.

Detailed description

Asthma continues to be a major public health problem in the US with high economic and social costs. Vulnerable ethnic communities are disproportionately affected by asthma as demonstrated by higher morbidity and mortality for these groups. We have completed two school-based, randomized trials of a web-based, computer-tailored asthma management intervention that targets urban teens (Puff City). The current study, Puff City in the Clinic, will be evaluated as a clinical tool by initiating the web-based behavioral intervention of asthma management in a clinical setting. However, the current paradigm for conducting such a trial is costly with respect to patient recruitment, intervention delivery, and data collection and management. To address these high costs, the study utilizes comparative effectiveness research (CER) pragmatic approaches to design a randomized controlled trial for patient recruitment and determination of eligibility, study monitoring (compliance with study regimen, participant retention and follow-up), and collection of clinical endpoints.

Interventions

BEHAVIORALTeens randomized to the experimental arm will receive 4 sessions plus a booster of web-based, tailored asthma management.

Web-based, computer-tailored asthma management intervention delivered in 4 sessions, plus a 6 month booster.

BEHAVIORALTeens in the control group will receive generic, web-based asthma education.

Web-based, generic asthma management intervention delivered in 4 sessions.

Sponsors

University of Michigan
CollaboratorOTHER
Augusta University
CollaboratorOTHER
National Heart, Lung, and Blood Institute (NHLBI)
CollaboratorNIH
Henry Ford Health System
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
OTHER
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
13 Years to 19 Years
Healthy volunteers
No

Inclusion criteria

* 13-19 years of age * Must be able to provide electronic assent and have consent from a parent/guardian if applicable * Diagnosis of asthma by meeting one of the following criteria within the last 12 months: * At least one emergency department diagnosis of asthma or * At least one acute inpatient encounter with asthma as the principal diagnosis or * At least four outpatient visits with an asthma diagnosis and at least 2 asthma medications dispensed or * At least four asthma medications dispensed

Exclusion criteria

* Inability to provide informed consent/assent * Lack of physician diagnosis of asthma * Other co-morbidities that make it impossible for the individual to participate.

Design outcomes

Primary

MeasureTime frameDescription
Asthma Control Test (ACT)12 MonthsComparison of ACT scores at 12 months after the randomization

Secondary

MeasureTime frameDescription
Asthma Exacerbations/Functional Status12 MonthsComparison of asthma exacerbations (asthma hospitalizations, emergency department visits, or oral corticosteroid dispensing)and functional status(e.g. self report of symptom-days, symptom nights, days of restricted activity, school/work days missed) at 12 months after randomization.

Other

MeasureTime frameDescription
The CostUp to 12 monthsThe cost of study intervention will be evaluated: The cost for participant enrollment with Electronic Medical Record (EMR) initiation; data collection and management with/o EMR initiation including assessing the reliability of EMR clinical outcomes/primary endpoints, compared to chart abstraction.
The Cost EffectivenessUp to 12 monthsThe cost effectiveness of Puff City intervention compared to controls without study intervention.

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026